B

Baton Rouge General Medical Center | Clinical Trials Office

Research site

(Unclaimed)

Location

9001 Summa Avenue 4th Floor, Suite 449, Baton Rouge, Louisiana, United States of America

Site insights

Top conditions

Top treatments

Bevacizumab

Carboplatin

Paclitaxel

Oxaliplatin

Doxorubicin Hydrochloride

Trastuzumab

Sorafenib Tosylate

Cisplatin

Sunitinib Malate

Irinotecan

Curious how this site stacks up to its peers?

Data sourced from clinicaltrials.gov

Work at this site?

CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.

Learn more and claim site

Active trials

4 of 76 total trials

A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System for the TREatment of Vascular Lesions Located in the InfrapoplitEal Arteries BeLow the Knee (DEEPER REVEAL)

This is a prospective, multicenter, single arm study designed to evaluate the safety and efficacy of the Temporary Bare Spur Stent System (Spur Stent...

Active, not recruiting

Critical Limb Ischemia

Peripheral Arterial Disease

Device: Bare Temporary Spur Stent System

Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns

This is a multi-center, pivotal study to assess the safety and effectiveness of a new method of treating severe burns using NovoSorb® Biodegradable T...

Active, not recruiting

Burns

Procedure: Standard of Care

Device: NovoSorb BTM

Evaluation of Treatment Strategies for Severe CaLcIfic Coronary Arteries: Orbital Atherectomy vs. Conventional Angioplasty Technique Prior to Implantation of Drug-Eluting StEnts: The ECLIPSE Trial

This trial will evaluate Orbital Atherectomy compared to conventional balloon angioplasty technique for the treatment of severely calcified lesions p...

Active, not recruiting

Ischemic Heart Disease

Coronary Artery Disease

Device: Orbital Atherectomy

Device: Balloon

GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

This clinical trial will evaluate the safety, tolerability and efficacy of GLS-1027 in the prevention of severe pneumonitis caused by SARS-CoV-2 infe...

Active, not recruiting

Pneumonitis

SARS-CoV Infection

Drug: GLS-1027

Drug: Placebo